Cancer Research Horizons is Cancer Research UK's innovation engine.

We take scientific breakthroughs from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. 

To date, we’ve played an instrumental role in forming over 60 spin-out companies and bringing 11 new cancer drugs to market, borne out of our pioneering research. We are the second biggest licensor of cancer research treatments globally and are part of Cancer Research UK – the world’s largest medical research charity. 

With exclusive rights to over £300m of world-class cancer research we’re a unique and powerful partner in the fight to beat cancer. We work closely with academia and industry to bridge the gap between research and the market, delivering maximum impact for patients. Every penny we make goes back into developing the next breakthroughs, helping bring forward the day when all cancer is conquered. 


Biotechnology

Health Care

Life Sciences

Medical Devices

Pharmaceutical

Cancer Research Horizons

Iain Foulkes

Steve Wedge

Gillian Fairfield

Parker Moss

Deborah Harland

Christoph Lengauer

Annalisa Jenkins

Tony Hickson

Cancer Research Horizons

Org chart

Similar companies